---
document_datetime: 2023-09-21 18:06:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/mabcampath-epar-all-authorised-presentations_en.pdf
document_name: mabcampath-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7593555
conversion_datetime: 2025-12-24 17:56:17.286684
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical form                               | Route of administration   | Packaging         | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|---------------------------------------------------|---------------------------|-------------------|---------------------------|----------------|
| EU/1/01/193/001 | MabCampath      | 10 mg/ml   | Concentrate for solution infusion                 | for Intravenous use       | Ampoule (glass) 3 | ml                        | 3 ampoules     |
| EU/1/01/193/002 | MabCampath      | 30 mg/ml   | Concentrate for solution for infusion Intravenous | use                       | Vial (glass) 1    | ml                        | 3 vials        |

1/1

Medicinal product no longer authorised